Literature DB >> 35096672

Association of specific haplotype of tumor necrosis factor-α and interleukin-1β polymorphisms with Helicobacter pylori infection and gastric carcinogenesis.

Fatemeh Nezamzadeh1, Mahboobeh Asadyun2, Amir Anbiyaiee3, Mansour Sedighi4, Abed Zahedi Bialvaei5, Younes Khalili6, Hamed Ebrahimzadeh Leylabadlo7, Aylin Esmailkhani8.   

Abstract

INTRODUCTION: The Helicobacter pylori infection and cytokine-mediated inflammatory responses play significant roles in the pathogenesis of gastric cancer (GC). This study was performed to determine the association between the risk of GC and genetic polymorphisms in interleukin (IL)-1β and tumor necrosis factor-alpha (TNF-α).
METHODS: The polymorphisms of IL-1β and TNF-α genes were analyzed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) in 290 patients who underwent endoscopy. Infection with H. pylori was diagnosed by histological analysis, rapid urease test, and PCR of gastric biopsy samples. Quantitative real-time PCR was performed to determine the relative mRNA expression levels.
RESULTS: No significant difference was detected in allele frequency and genotype of all studied polymorphisms between chronic gastritis (CG), GC and healthy individuals. IL-1β mRNA was down-regulated in both gastritis (relative quantification (RQ)=0.447) and the GC groups (RQ=0.151). In contrast, the expression of TNF-α was up-regulated in the GC group (RQ=2.817) compared to the gastritis group (RQ=0.861).
CONCLUSIONS: The studied single-nucleotide polymorphisms are not risk factors for development of CG and GC. However, H. pylori infection causes a huge increase in the TNF-α expression in GC patients. GERMS.

Entities:  

Keywords:  Gastric cancer; Helicobacter pylori; IL-1β; TNF-α; chronic gastritis; gene polymorphisms

Year:  2021        PMID: 35096672      PMCID: PMC8789352          DOI: 10.18683/germs.2021.1290

Source DB:  PubMed          Journal:  Germs        ISSN: 2248-2997


  27 in total

1.  Association of tumor necrosis factor alpha gene polymorphisms with Helicobacter pylori infection in dyspeptic patients in Sri Lanka.

Authors:  Piyumali Sandareka Arachchi; Manjula Manoji Weerasekera; Bimalka Senevirathna; Deepaka Weerasekera; Neluka Fernando; Chinthika Prabhashinie Gunasekara
Journal:  Microbiol Immunol       Date:  2018-04-28       Impact factor: 1.955

2.  Influences of proinflammatory and anti-inflammatory cytokine polymorphisms on eradication rates of clarithromycin-sensitive strains of Helicobacter pylori by triple therapy.

Authors:  Mitsushige Sugimoto; Takahisa Furuta; Naohito Shirai; Mutsuhiro Ikuma; Akira Hishida; Takashi Ishizaki
Journal:  Clin Pharmacol Ther       Date:  2006-06-08       Impact factor: 6.875

3.  Genetic predisposition to Helicobacter pylori-induced gastric precancerous conditions.

Authors:  Asahi Hishida; Keitaro Matsuo; Yasuyuki Goto; Nobuyuki Hamajima
Journal:  World J Gastrointest Oncol       Date:  2010-10-15

4.  Interleukin-1B gene promoter variants are associated with an increased risk of gastric cancer in a Chinese population.

Authors:  Jie Yang; Zhibin Hu; Yaochu Xu; Jin Shen; Juyin Niu; Xu Hu; Jiantao Guo; Qingyi Wei; Xinru Wang; Hongbing Shen
Journal:  Cancer Lett       Date:  2004-11-25       Impact factor: 8.679

5.  Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan.

Authors:  Takahisa Furuta; Emad M El-Omar; Fang Xiao; Naohito Shirai; Misako Takashima; Haruhiko Sugimura; Haruhiko Sugimurra
Journal:  Gastroenterology       Date:  2002-07       Impact factor: 22.682

6.  Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus.

Authors:  Jyh-Ming Liou; Peter Malfertheiner; Yi-Chia Lee; Bor-Shyang Sheu; Kentaro Sugano; Hsiu-Chi Cheng; Khay-Guan Yeoh; Ping-I Hsu; Khean-Lee Goh; Varocha Mahachai; Takuji Gotoda; Wei-Lun Chang; Mei-Jyh Chen; Tsung-Hsien Chiang; Chieh-Chang Chen; Chun-Ying Wu; Alex Hwong-Ruey Leow; Jeng-Yih Wu; Deng-Chyang Wu; Tzu-Chan Hong; Hong Lu; Yoshio Yamaoka; Francis Megraud; Francis K L Chan; Joseph Jy Sung; Jaw-Town Lin; David Y Graham; Ming-Shiang Wu; Emad M El-Omar
Journal:  Gut       Date:  2020-10-01       Impact factor: 23.059

7.  Eradication rate of Helicobacter pylori according to genotypes of CYP2C19, IL-1B, and TNF-A.

Authors:  Yoshiko Ishida; Yasuyuki Goto; Takaaki Kondo; Mio Kurata; Kazuko Nishio; Sayo Kawai; Tomo Osafune; Mariko Naito; Nobuyuki Hamajima
Journal:  Int J Med Sci       Date:  2006-09-10       Impact factor: 3.738

Review 8.  Helicobacter pylori and gastric cancer: a state of the art review.

Authors:  Sauid Ishaq; Lois Nunn
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2015

9.  Investigation of -308G>A and -1031T>C polymorphisms in the TNFA promoter region in Polish peptic ulcer patients.

Authors:  Aleksandra Sałagacka; Marta Żebrowska; Agnieszka Jeleń; Marek Mirowski; Ewa Balcerczak
Journal:  Gut Liver       Date:  2014-11-15       Impact factor: 4.519

10.  Associations between cytokine gene polymorphisms and susceptibility to Helicobacter pylori infection and Helicobacter pylori related gastric cancer, peptic ulcer disease: A meta-analysis.

Authors:  Jingjing Ma; Dandan Wu; Xue Hu; Jiao Li; Mingwei Cao; Weiguo Dong
Journal:  PLoS One       Date:  2017-04-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.